Skip to main content
. 2014 May 29;5(2):87–99.

Table 8.

Association of -308G>A polymorphism (alleles) of the TNF-α gene with clinical variables of cystic fibrosis patients

Clinical variables Groups Allelic distribution

G allele OR (95%CI) A Allele OR (95%CI)
Age at diagnosis <12 months 13 1.01 (0.39-2.69) 41 0.99 (0.37-2.56)
13 to 36 months 5 1.56 (0.44-5.06) 11 0.64 (0.20-2.29)
>36 months 5 0.69 (0.21-2.05) 21 1.45 (0.48-4.87)
Onset of pulmonary symptoms <12 months 16 0.75 (0.26-2.25) 52 1.33 (0.45-3.79)
13 to 36 months 7 3.81 (1.13-12.97) 7 0.26 (0.08-0.89)
>36 months 0 - 10 -
No clinical symptom 0 - 2 -
Onset of digestive symptoms <12 months 13 0.80 (0.22-3.29) 49 1.25 (0.30-4.48)
13 to 36 months 2 1.22 (0.16-6.44) 6 0.82 (0.16-6.43)
>36 months 2 1.22 (0.16-6.44) 6 0.82 (0.16-6.43)
Age for the first infection by Pseudomonas aeruginosa <12 months 21 66.77 (15.18-482.7) 9 0.15 (0.002-0.07)
13 to 36 months 2 0.15 (0.02-0.62) 24 6.69 (1.62-45.66)
>36 months 0 - 28 -
No clinical symptom 0 - 10 -
Forced expiratory volume in first second of the FVC Normal (>80%) 6 2.30 (0.52-12.34) 24 0.44 (0.08-1.94)
Mild (60-80%) 3 1.49 (0.27-6.91) 13 0.67 (0.14-3.70)
Moderate (40-60%) 0 - 6 -
Severe (<40%) 0 - 9 -
Shwachman-Kulczycki score Excellent (86-100) 6 2.41 (0.60-9.84) 8 0.41 (0.10-1.68)
Good (71-85) 5 1.51 (0.36-6.08) 9 0.66 (0.16-2.77)
Mild (56-70) 2 - 0 -
Moderate (41-55) 0 - 12 -
Severe (≤40) 0 - 2 -
Kanga score Exacerbated 2 0.87 (0.12-4.20) 8 1.15 (0.24-8.58)
Non exacerbated 17 1 59 1
Transcutaneous oxygen saturation of hemoglobin Normal (>95%) 18 9.24 (1.53-206.1) 44 0.11 (0.005-0.66)
Mild (91-95%) 1 0.14 (0.006-0.87) 19 7.01 (1.14-157.4)
Moderate (85-90%) 0 - 2 -
Severe (<85%) 0 - 2 -

TNF-α = tumor necrosis factor; FVC = forced ventilator capacity. Positive p-value is in bold. Statistical analysis performed by χ2 test and Fisher’s exact test.